INCONTROL METRIX 3000 ATRIAL DEFIBRILLATOR CLINICALS
This article was originally published in The Gray Sheet
Executive Summary
INCONTROL METRIX 3000 ATRIAL DEFIBRILLATOR CLINICALS are slated to begin in early 1995, the company says in a filing for an initial public offering. Implanted beneath the collarbone with transvenous leads connecting it to the heart, the Metfix system is designed to detect and correct atrial fibrillation. The device is the first product under development by Redmond, Washington-based InControl.